Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Liposomal Morphine Injection bulk supplier for pharma manufacturers

Liposomal Morphine Injection 10 mg/mL Suppliers & Bulk Manufacturers

Available Forms: Injectable liposomal formulations

Available Strengths: 10 mg/mL

Reference Brands: DepoDur

Category: Liposomal Drug Delivery

Liposomal morphine works by releasing encapsulated morphine slowly, providing extended pain relief by targeting opioid receptors in the brain and spinal cord. Benefits include prolonged analgesia, reduced opioid doses, fewer side effects, and improved patient comfort, especially after surgery or in chronic pain management.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Liposomal morphine is regulated in the EU and US, supported by dossiers demonstrating safety, efficacy, and manufacturing quality in compliance with GMP standards. In the US, FDA approval involves validation, safety assessments, and clinical data, while in the EU, CE marking certifies conformity with MDR standards. These formulations undergo validation, stability testing, and audits, with comprehensive documentation including safety profiles, clinical trial results, and manufacturing practices. For licensing procedures, approved dossiers, and the latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to high-quality liposomal morphine, supporting effective pain management in surgical, acute, and chronic settings worldwide while minimizing side effects and opioid requirements.

Liposomal Morphine Injection — third party manufacturing & bulk supply

Liposomal Morphine Injection 10 mg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Liposomal Morphine Injection is supplied as Injectable liposomal formulations — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Liposomal Morphine Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Liposomal Morphine Injection →
Back to Listing

Frequently Asked Questions

Liposomal Morphine Injection is listed as Injectable liposomal formulations in 10 mg/mL. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Liposomal Morphine Injection is referenced against DepoDur. Reference brands are shown for identification only and remain the property of their respective trademark owners.

Related Products

Liposomal Resveratrol Capsules

Strength:
100 mg to 500 mg per serving

Form: Capsules

Reference Brands: Epigenetics

View Details
Liposomal Bupivacaine Injection

Strength:
133 mg/20 mL (6.6 mg/mL)

Form: Liposomal injectable solution

Reference Brands: EXPAREL

View Details
Liposomal Vitamin C Softgels

Strength:
500 mg to 2000 mg per serving,

Form: Capsules or softgels

Reference Brands: LivOn Labs, Quicksilver Scientific, Dr. Mercola, NutraMedix

View Details
Cytarabine + Daunorubicin Liposomal

Strength:
44mg/ 100 ml

Form: Liposomal injectable

Reference Brands: Vyxeos

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.